GLP-1 Receptor Agonists in Youth: Promising Outcomes, Remaining Questions
Description
A comprehensive meta-analysis points to modest improvements in weight, glycemic, and cardiometabolic outcomes, but GI side effects are common and long-term safety remains uncertain.
